To evaluate the efficacy and safety of Neoretin Discrom Control Serum for the treatment of melasma. Methods: A clinical trial in 36 melasma patients treated with Neoretin Discrom Control Serum for 4 months. Patients were re-examined at weeks 4, 8, 12, 16; Facial pictures by digital camera were taken and were evaluated the improvement of melasma on the MASI scale, on dermoscopy, the change in Melanin index through the Mexameter, clinical side effects and patient satisfaction during and after treatment was noted. |
